🟢 GYRE is trading 5.6% up today after filing a resale shelf registration for 30.22 million shares

GYRE is trading 5.6% up at $6.47 amid active trading as investors digest a new shelf registration filing for the potential resale of common stock.

• Gyre Therapeutics filed a Form S-3 related to the potential resale of 30.22 million shares by existing holders.
• MarketWatch highlighted the registration, noting that while the filing is drawing significant attention, it does not immediately dilute existing shareholders.
• The stock is seeing increased volume following the disclosure of the filing on June 23, 2026.